Skip to main content

Characterization of Apolipoprotein A-I Pathways in Idiopathic Pulmonary Fibrosis

General Information

Age Group

Adult

Status

Active

Protocol Number

APO-A 1

Offered At

National Institutes of Health
Bethesda, MD

Principal Investigator

Steven Nathan, MD
Nargues Weir, MD
Stewart Levine, MD

Eligibility Information

  • People at least 18 years old with IPF
  • Healthy volunteers at least 18 years old

Ineligibility Information

  • Female subjects who are pregnant or lactating